GAO Health Care Reports · September 24, 2026 · Primary source
Private Health Insurance: Federal and State Oversight of Contraceptive Coverage Requirements
What the document says
The GAO report examines federal and state oversight of private health plan compliance with contraceptive coverage requirements under the Patient Protection and Affordable Care Act (PPACA/ACA). Private health plans are generally required to cover the full range of FDA-approved contraceptives for women without cost-sharing, including oral contraceptives, intrauterine devices, and female sterilization services. Oversight responsibility is divided among DOL (private employer-sponsored group health plans), CMS (non-federal governmental plans, qualified health plans on federally-facilitated exchanges, and plans in states lacking enforcement capacity), and state regulators (individual and certain group health plans sold in-state). DOL identified noncompliance with federal contraceptive coverage requirements in three investigations conducted within the last six years. In one documented instance, a pharmacy benefit manager required enrollees to attempt other contraceptive methods before covering the medically necessary, preferred method at no cost-sharing, a step-therapy practice the DOL found to violate coverage requirements. Following DOL action, the PBM revised its practices and reprocessed the associated claims. CMS identified noncompliance in three of five market conduct examinations it conducted over the same six-year period. In one instance, a health plan failed to provide contraceptive services without cost-sharing as required. CMS directed that plan to revise its practices and reprocess claims. CMS oversight activities include annual plan reviews and certification, individual complaint investigations, and market conduct examinations targeting systemic compliance issues. GAO's methodology included analysis of contraceptive prescription purchase data from the Agency for Healthcare Research and Quality, review of federal guidance issued by CMS and DOL, and interviews with officials from DOL, CMS, six states, selected health plans, and stakeholder organizations representing enrollees and providers. State regulators perform premarket plan reviews, complaint collection, and market conduct examinations for plans within their jurisdiction.
What this may mean
Applies to private employer-sponsored group health plans, non-federal governmental plans, qualified health plans on federally-facilitated exchanges, and individual market plans subject to ACA contraceptive coverage mandates. Puts PBM step-therapy protocols and health plan cost-sharing practices for contraceptives at issue under DOL and CMS enforcement authority. DOL, CMS, and state regulators each hold active investigation and market conduct examination authority over plans within their respective jurisdictions.
Informational only. Not legal, medical, financial, or other professional advice. Always consult a qualified professional familiar with your specific facts before relying on any item.
Related items
- GAO Health Care Reports · October 5, 2026Medicare Part D: Payments and Contracts Between Pharmacies and Plan Sponsors That Are Vertically IntegratedScore 70
- GAO Health Care Reports · October 16, 2026Private Health Insurance: Market Concentration in 2024 Was Generally Higher Than in 2011Score 61
- GAO Health Care Reports · October 6, 2026Rural Health Transformation Program: Early Implementation Actions and Monitoring PlansScore 60
- GAO Health Care Reports · October 16, 2026Research Security: NIH Action Needed to Strengthen Foreign Interference Risk ManagementScore 30
- GAO Health Care Reports · October 16, 2026Service Member Records: DOD Needs to Address Improper and Delayed Releasing of Personnel and Health InformationScore 26
- GAO Health Care Reports · October 5, 2026Concrete Masonry Promotion Program: Commerce Could Enhance Its Oversight ControlsScore 26